Skip to content
PICO Portalanswers from OpenAlex

Rituximab for IgG4-related disease: a prospective, open-label trial

PaperCitations, authors & open-access status

Rituximab for IgG4-related disease: a prospective, open-label trial is a paper indexed in PICO Portal from OpenAlex.

How many citations does Rituximab for IgG4-related disease: a prospective, open-label trial have?

PICO Portalcitation count

Rituximab for IgG4-related disease: a prospective, open-label trial has 714 citations in the OpenAlex counts PICO Portal stores.

When was Rituximab for IgG4-related disease: a prospective, open-label trial published?

PICO Portalyear

Rituximab for IgG4-related disease: a prospective, open-label trial has 2015 year in the PICO Portal index.

What is the open-access status of Rituximab for IgG4-related disease: a prospective, open-label trial?

PICO Portaloa status

Rituximab for IgG4-related disease: a prospective, open-label trial has closed oa status in the PICO Portal index.

What is the DOI of Rituximab for IgG4-related disease: a prospective, open-label trial?

PICO Portaldoi

The DOI for Rituximab for IgG4-related disease: a prospective, open-label trial is on the source record.

What is the PMID of Rituximab for IgG4-related disease: a prospective, open-label trial?

PICO Portalpmid

The PMID for Rituximab for IgG4-related disease: a prospective, open-label trial is on the source record.

What is the OpenAlex record for Rituximab for IgG4-related disease: a prospective, open-label trial?

PICO Portalopenalex

The OpenAlex for Rituximab for IgG4-related disease: a prospective, open-label trial is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial